COVID-19 Impact on Global Biologics Drug Development Market Size, Status and Forecast 2020-2026
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics Drug Development market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologics Drug Development industry.
Based on our recent survey, we have several different scenarios about the Biologics Drug Development YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologics Drug Development will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Drug Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Drug Development market in terms of revenue.
Players, stakeholders, and other participants in the global Biologics Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologics Drug Development market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologics Drug Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Drug Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Drug Development market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics Drug Development market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologics Drug Development industry.
Based on our recent survey, we have several different scenarios about the Biologics Drug Development YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologics Drug Development will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Drug Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Drug Development market in terms of revenue.
Players, stakeholders, and other participants in the global Biologics Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologics Drug Development market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologics Drug Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Drug Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Drug Development market.
The following players are covered in this report:
- Abbvie
- Allergan
- Boehringer Ingelheim
- Charles River Laboratories
- Catalent
- Lonza Group
- Amgen
- Sanofi
- Clinical Manufacturing
- Formulation Development
- Bioassay Development
- Analytical Services
- In-House
- Outsource
- Pharma Excess
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Drug Development Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Clinical Manufacturing
1.4.3 Formulation Development
1.4.4 Bioassay Development
1.4.5 Analytical Services
1.5 Market by Application
1.5.1 Global Biologics Drug Development Market Share by Application: 2020 VS 2026
1.5.2 In-House
1.5.3 Outsource
1.5.4 Pharma Excess
1.6 Coronavirus Disease 2019 (Covid-19): Biologics Drug Development Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologics Drug Development Industry
1.6.1.1 Biologics Drug Development Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologics Drug Development Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologics Drug Development Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biologics Drug Development Market Perspective (2015-2026)
2.2 Biologics Drug Development Growth Trends by Regions
2.2.1 Biologics Drug Development Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologics Drug Development Historic Market Share by Regions (2015-2020)
2.2.3 Biologics Drug Development Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologics Drug Development Market Growth Strategy
2.3.6 Primary Interviews with Key Biologics Drug Development Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biologics Drug Development Players by Market Size
3.1.1 Global Top Biologics Drug Development Players by Revenue (2015-2020)
3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologics Drug Development Market Concentration Ratio
3.2.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2019
3.3 Biologics Drug Development Key Players Head office and Area Served
3.4 Key Players Biologics Drug Development Product Solution and Service
3.5 Date of Enter into Biologics Drug Development Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biologics Drug Development Historic Market Size by Type (2015-2020)
4.2 Global Biologics Drug Development Forecasted Market Size by Type (2021-2026)
5 BIOLOGICS DRUG DEVELOPMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biologics Drug Development Market Size by Application (2015-2020)
5.2 Global Biologics Drug Development Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biologics Drug Development Market Size (2015-2020)
6.2 Biologics Drug Development Key Players in North America (2019-2020)
6.3 North America Biologics Drug Development Market Size by Type (2015-2020)
6.4 North America Biologics Drug Development Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biologics Drug Development Market Size (2015-2020)
7.2 Biologics Drug Development Key Players in Europe (2019-2020)
7.3 Europe Biologics Drug Development Market Size by Type (2015-2020)
7.4 Europe Biologics Drug Development Market Size by Application (2015-2020)
8 CHINA
8.1 China Biologics Drug Development Market Size (2015-2020)
8.2 Biologics Drug Development Key Players in China (2019-2020)
8.3 China Biologics Drug Development Market Size by Type (2015-2020)
8.4 China Biologics Drug Development Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biologics Drug Development Market Size (2015-2020)
9.2 Biologics Drug Development Key Players in Japan (2019-2020)
9.3 Japan Biologics Drug Development Market Size by Type (2015-2020)
9.4 Japan Biologics Drug Development Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biologics Drug Development Market Size (2015-2020)
10.2 Biologics Drug Development Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologics Drug Development Market Size by Type (2015-2020)
10.4 Southeast Asia Biologics Drug Development Market Size by Application (2015-2020)
11 INDIA
11.1 India Biologics Drug Development Market Size (2015-2020)
11.2 Biologics Drug Development Key Players in India (2019-2020)
11.3 India Biologics Drug Development Market Size by Type (2015-2020)
11.4 India Biologics Drug Development Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biologics Drug Development Market Size (2015-2020)
12.2 Biologics Drug Development Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologics Drug Development Market Size by Type (2015-2020)
12.4 Central & South America Biologics Drug Development Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview and Its Total Revenue
13.1.3 Abbvie Biologics Drug Development Introduction
13.1.4 Abbvie Revenue in Biologics Drug Development Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview and Its Total Revenue
13.2.3 Allergan Biologics Drug Development Introduction
13.2.4 Allergan Revenue in Biologics Drug Development Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Details
13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
13.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2015-2020)
13.3.5 Boehringer Ingelheim Recent Development
13.4 Charles River Laboratories
13.4.1 Charles River Laboratories Company Details
13.4.2 Charles River Laboratories Business Overview and Its Total Revenue
13.4.3 Charles River Laboratories Biologics Drug Development Introduction
13.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2015-2020)
13.4.5 Charles River Laboratories Recent Development
13.5 Catalent
13.5.1 Catalent Company Details
13.5.2 Catalent Business Overview and Its Total Revenue
13.5.3 Catalent Biologics Drug Development Introduction
13.5.4 Catalent Revenue in Biologics Drug Development Business (2015-2020)
13.5.5 Catalent Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview and Its Total Revenue
13.6.3 Lonza Group Biologics Drug Development Introduction
13.6.4 Lonza Group Revenue in Biologics Drug Development Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview and Its Total Revenue
13.7.3 Amgen Biologics Drug Development Introduction
13.7.4 Amgen Revenue in Biologics Drug Development Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Biologics Drug Development Introduction
13.8.4 Sanofi Revenue in Biologics Drug Development Business (2015-2020)
13.8.5 Sanofi Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Drug Development Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Clinical Manufacturing
1.4.3 Formulation Development
1.4.4 Bioassay Development
1.4.5 Analytical Services
1.5 Market by Application
1.5.1 Global Biologics Drug Development Market Share by Application: 2020 VS 2026
1.5.2 In-House
1.5.3 Outsource
1.5.4 Pharma Excess
1.6 Coronavirus Disease 2019 (Covid-19): Biologics Drug Development Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologics Drug Development Industry
1.6.1.1 Biologics Drug Development Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologics Drug Development Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologics Drug Development Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biologics Drug Development Market Perspective (2015-2026)
2.2 Biologics Drug Development Growth Trends by Regions
2.2.1 Biologics Drug Development Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologics Drug Development Historic Market Share by Regions (2015-2020)
2.2.3 Biologics Drug Development Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologics Drug Development Market Growth Strategy
2.3.6 Primary Interviews with Key Biologics Drug Development Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biologics Drug Development Players by Market Size
3.1.1 Global Top Biologics Drug Development Players by Revenue (2015-2020)
3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologics Drug Development Market Concentration Ratio
3.2.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2019
3.3 Biologics Drug Development Key Players Head office and Area Served
3.4 Key Players Biologics Drug Development Product Solution and Service
3.5 Date of Enter into Biologics Drug Development Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biologics Drug Development Historic Market Size by Type (2015-2020)
4.2 Global Biologics Drug Development Forecasted Market Size by Type (2021-2026)
5 BIOLOGICS DRUG DEVELOPMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biologics Drug Development Market Size by Application (2015-2020)
5.2 Global Biologics Drug Development Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biologics Drug Development Market Size (2015-2020)
6.2 Biologics Drug Development Key Players in North America (2019-2020)
6.3 North America Biologics Drug Development Market Size by Type (2015-2020)
6.4 North America Biologics Drug Development Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biologics Drug Development Market Size (2015-2020)
7.2 Biologics Drug Development Key Players in Europe (2019-2020)
7.3 Europe Biologics Drug Development Market Size by Type (2015-2020)
7.4 Europe Biologics Drug Development Market Size by Application (2015-2020)
8 CHINA
8.1 China Biologics Drug Development Market Size (2015-2020)
8.2 Biologics Drug Development Key Players in China (2019-2020)
8.3 China Biologics Drug Development Market Size by Type (2015-2020)
8.4 China Biologics Drug Development Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biologics Drug Development Market Size (2015-2020)
9.2 Biologics Drug Development Key Players in Japan (2019-2020)
9.3 Japan Biologics Drug Development Market Size by Type (2015-2020)
9.4 Japan Biologics Drug Development Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biologics Drug Development Market Size (2015-2020)
10.2 Biologics Drug Development Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologics Drug Development Market Size by Type (2015-2020)
10.4 Southeast Asia Biologics Drug Development Market Size by Application (2015-2020)
11 INDIA
11.1 India Biologics Drug Development Market Size (2015-2020)
11.2 Biologics Drug Development Key Players in India (2019-2020)
11.3 India Biologics Drug Development Market Size by Type (2015-2020)
11.4 India Biologics Drug Development Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biologics Drug Development Market Size (2015-2020)
12.2 Biologics Drug Development Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologics Drug Development Market Size by Type (2015-2020)
12.4 Central & South America Biologics Drug Development Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview and Its Total Revenue
13.1.3 Abbvie Biologics Drug Development Introduction
13.1.4 Abbvie Revenue in Biologics Drug Development Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview and Its Total Revenue
13.2.3 Allergan Biologics Drug Development Introduction
13.2.4 Allergan Revenue in Biologics Drug Development Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Details
13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
13.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2015-2020)
13.3.5 Boehringer Ingelheim Recent Development
13.4 Charles River Laboratories
13.4.1 Charles River Laboratories Company Details
13.4.2 Charles River Laboratories Business Overview and Its Total Revenue
13.4.3 Charles River Laboratories Biologics Drug Development Introduction
13.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2015-2020)
13.4.5 Charles River Laboratories Recent Development
13.5 Catalent
13.5.1 Catalent Company Details
13.5.2 Catalent Business Overview and Its Total Revenue
13.5.3 Catalent Biologics Drug Development Introduction
13.5.4 Catalent Revenue in Biologics Drug Development Business (2015-2020)
13.5.5 Catalent Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview and Its Total Revenue
13.6.3 Lonza Group Biologics Drug Development Introduction
13.6.4 Lonza Group Revenue in Biologics Drug Development Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview and Its Total Revenue
13.7.3 Amgen Biologics Drug Development Introduction
13.7.4 Amgen Revenue in Biologics Drug Development Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Biologics Drug Development Introduction
13.8.4 Sanofi Revenue in Biologics Drug Development Business (2015-2020)
13.8.5 Sanofi Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Biologics Drug Development Key Market Segments
Table 2. Key Players Covered: Ranking by Biologics Drug Development Revenue
Table 3. Ranking of Global Top Biologics Drug Development Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologics Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Clinical Manufacturing
Table 6. Key Players of Formulation Development
Table 7. Key Players of Bioassay Development
Table 8. Key Players of Analytical Services
Table 9. COVID-19 Impact Global Market: (Four Biologics Drug Development Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Biologics Drug Development Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Biologics Drug Development Players to Combat Covid-19 Impact
Table 14. Global Biologics Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Biologics Drug Development Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Biologics Drug Development Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Biologics Drug Development Market Share by Regions (2015-2020)
Table 18. Global Biologics Drug Development Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Biologics Drug Development Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Biologics Drug Development Market Growth Strategy
Table 24. Main Points Interviewed from Key Biologics Drug Development Players
Table 25. Global Biologics Drug Development Revenue by Players (2015-2020) (Million US$)
Table 26. Global Biologics Drug Development Market Share by Players (2015-2020)
Table 27. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2019)
Table 28. Global Biologics Drug Development by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Biologics Drug Development Product Solution and Service
Table 31. Date of Enter into Biologics Drug Development Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 34. Global Biologics Drug Development Market Size Share by Type (2015-2020)
Table 35. Global Biologics Drug Development Revenue Market Share by Type (2021-2026)
Table 36. Global Biologics Drug Development Market Size Share by Application (2015-2020)
Table 37. Global Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 38. Global Biologics Drug Development Market Size Share by Application (2021-2026)
Table 39. North America Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Biologics Drug Development Market Share (2019-2020)
Table 41. North America Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 42. North America Biologics Drug Development Market Share by Type (2015-2020)
Table 43. North America Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 44. North America Biologics Drug Development Market Share by Application (2015-2020)
Table 45. Europe Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Biologics Drug Development Market Share (2019-2020)
Table 47. Europe Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Biologics Drug Development Market Share by Type (2015-2020)
Table 49. Europe Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Biologics Drug Development Market Share by Application (2015-2020)
Table 51. China Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 52. China Key Players Biologics Drug Development Market Share (2019-2020)
Table 53. China Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 54. China Biologics Drug Development Market Share by Type (2015-2020)
Table 55. China Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 56. China Biologics Drug Development Market Share by Application (2015-2020)
Table 57. Japan Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Biologics Drug Development Market Share (2019-2020)
Table 59. Japan Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Biologics Drug Development Market Share by Type (2015-2020)
Table 61. Japan Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Biologics Drug Development Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Biologics Drug Development Market Share (2019-2020)
Table 65. Southeast Asia Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Biologics Drug Development Market Share by Type (2015-2020)
Table 67. Southeast Asia Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Biologics Drug Development Market Share by Application (2015-2020)
Table 69. India Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 70. India Key Players Biologics Drug Development Market Share (2019-2020)
Table 71. India Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 72. India Biologics Drug Development Market Share by Type (2015-2020)
Table 73. India Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 74. India Biologics Drug Development Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Biologics Drug Development Market Share (2019-2020)
Table 77. Central & South America Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Biologics Drug Development Market Share by Type (2015-2020)
Table 79. Central & South America Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Biologics Drug Development Market Share by Application (2015-2020)
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Product
Table 84. Abbvie Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 85. Abbvie Recent Development
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Product
Table 89. Allergan Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 90. Allergan Recent Development
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 95. Boehringer Ingelheim Recent Development
Table 96. Charles River Laboratories Company Details
Table 97. Charles River Laboratories Business Overview
Table 98. Charles River Laboratories Product
Table 99. Charles River Laboratories Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 100. Charles River Laboratories Recent Development
Table 101. Catalent Company Details
Table 102. Catalent Business Overview
Table 103. Catalent Product
Table 104. Catalent Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 105. Catalent Recent Development
Table 106. Lonza Group Company Details
Table 107. Lonza Group Business Overview
Table 108. Lonza Group Product
Table 109. Lonza Group Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 110. Lonza Group Recent Development
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Product
Table 114. Amgen Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. Sanofi Business Overview
Table 117. Sanofi Product
Table 118. Sanofi Company Details
Table 119. Sanofi Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 120. Sanofi Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 1. Biologics Drug Development Key Market Segments
Table 2. Key Players Covered: Ranking by Biologics Drug Development Revenue
Table 3. Ranking of Global Top Biologics Drug Development Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologics Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Clinical Manufacturing
Table 6. Key Players of Formulation Development
Table 7. Key Players of Bioassay Development
Table 8. Key Players of Analytical Services
Table 9. COVID-19 Impact Global Market: (Four Biologics Drug Development Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Biologics Drug Development Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Biologics Drug Development Players to Combat Covid-19 Impact
Table 14. Global Biologics Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Biologics Drug Development Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Biologics Drug Development Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Biologics Drug Development Market Share by Regions (2015-2020)
Table 18. Global Biologics Drug Development Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Biologics Drug Development Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Biologics Drug Development Market Growth Strategy
Table 24. Main Points Interviewed from Key Biologics Drug Development Players
Table 25. Global Biologics Drug Development Revenue by Players (2015-2020) (Million US$)
Table 26. Global Biologics Drug Development Market Share by Players (2015-2020)
Table 27. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2019)
Table 28. Global Biologics Drug Development by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Biologics Drug Development Product Solution and Service
Table 31. Date of Enter into Biologics Drug Development Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 34. Global Biologics Drug Development Market Size Share by Type (2015-2020)
Table 35. Global Biologics Drug Development Revenue Market Share by Type (2021-2026)
Table 36. Global Biologics Drug Development Market Size Share by Application (2015-2020)
Table 37. Global Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 38. Global Biologics Drug Development Market Size Share by Application (2021-2026)
Table 39. North America Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Biologics Drug Development Market Share (2019-2020)
Table 41. North America Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 42. North America Biologics Drug Development Market Share by Type (2015-2020)
Table 43. North America Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 44. North America Biologics Drug Development Market Share by Application (2015-2020)
Table 45. Europe Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Biologics Drug Development Market Share (2019-2020)
Table 47. Europe Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Biologics Drug Development Market Share by Type (2015-2020)
Table 49. Europe Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Biologics Drug Development Market Share by Application (2015-2020)
Table 51. China Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 52. China Key Players Biologics Drug Development Market Share (2019-2020)
Table 53. China Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 54. China Biologics Drug Development Market Share by Type (2015-2020)
Table 55. China Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 56. China Biologics Drug Development Market Share by Application (2015-2020)
Table 57. Japan Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Biologics Drug Development Market Share (2019-2020)
Table 59. Japan Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Biologics Drug Development Market Share by Type (2015-2020)
Table 61. Japan Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Biologics Drug Development Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Biologics Drug Development Market Share (2019-2020)
Table 65. Southeast Asia Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Biologics Drug Development Market Share by Type (2015-2020)
Table 67. Southeast Asia Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Biologics Drug Development Market Share by Application (2015-2020)
Table 69. India Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 70. India Key Players Biologics Drug Development Market Share (2019-2020)
Table 71. India Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 72. India Biologics Drug Development Market Share by Type (2015-2020)
Table 73. India Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 74. India Biologics Drug Development Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Biologics Drug Development Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Biologics Drug Development Market Share (2019-2020)
Table 77. Central & South America Biologics Drug Development Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Biologics Drug Development Market Share by Type (2015-2020)
Table 79. Central & South America Biologics Drug Development Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Biologics Drug Development Market Share by Application (2015-2020)
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Product
Table 84. Abbvie Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 85. Abbvie Recent Development
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Product
Table 89. Allergan Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 90. Allergan Recent Development
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 95. Boehringer Ingelheim Recent Development
Table 96. Charles River Laboratories Company Details
Table 97. Charles River Laboratories Business Overview
Table 98. Charles River Laboratories Product
Table 99. Charles River Laboratories Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 100. Charles River Laboratories Recent Development
Table 101. Catalent Company Details
Table 102. Catalent Business Overview
Table 103. Catalent Product
Table 104. Catalent Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 105. Catalent Recent Development
Table 106. Lonza Group Company Details
Table 107. Lonza Group Business Overview
Table 108. Lonza Group Product
Table 109. Lonza Group Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 110. Lonza Group Recent Development
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Product
Table 114. Amgen Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. Sanofi Business Overview
Table 117. Sanofi Product
Table 118. Sanofi Company Details
Table 119. Sanofi Revenue in Biologics Drug Development Business (2015-2020) (Million US$)
Table 120. Sanofi Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Biologics Drug Development Market Share by Type: 2020 VS 2026
Figure 2. Clinical Manufacturing Features
Figure 3. Formulation Development Features
Figure 4. Bioassay Development Features
Figure 5. Analytical Services Features
Figure 6. Global Biologics Drug Development Market Share by Application: 2020 VS 2026
Figure 7. In-House Case Studies
Figure 8. Outsource Case Studies
Figure 9. Pharma Excess Case Studies
Figure 10. Biologics Drug Development Report Years Considered
Figure 11. Global Biologics Drug Development Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Biologics Drug Development Market Share by Regions: 2020 VS 2026
Figure 13. Global Biologics Drug Development Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Biologics Drug Development Market Share by Players in 2019
Figure 16. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Biologics Drug Development Revenue in 2019
Figure 18. North America Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 27. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 29. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 31. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 33. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalent Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 35. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 37. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Amgen Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 1. Global Biologics Drug Development Market Share by Type: 2020 VS 2026
Figure 2. Clinical Manufacturing Features
Figure 3. Formulation Development Features
Figure 4. Bioassay Development Features
Figure 5. Analytical Services Features
Figure 6. Global Biologics Drug Development Market Share by Application: 2020 VS 2026
Figure 7. In-House Case Studies
Figure 8. Outsource Case Studies
Figure 9. Pharma Excess Case Studies
Figure 10. Biologics Drug Development Report Years Considered
Figure 11. Global Biologics Drug Development Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Biologics Drug Development Market Share by Regions: 2020 VS 2026
Figure 13. Global Biologics Drug Development Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Biologics Drug Development Market Share by Players in 2019
Figure 16. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Biologics Drug Development Revenue in 2019
Figure 18. North America Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Biologics Drug Development Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 27. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 29. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 31. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 33. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalent Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 35. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 37. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Amgen Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
